SELLAS Life Sciences (SLS) Goodwill & Intangibles (2011 - 2026)
SELLAS Life Sciences (SLS) reported Goodwill & Intangibles of $1.9 million for Q1 2026, little changed year-over-year from $1.9 million in Q1 2025, and little changed quarter-over-quarter from $1.9 million in Q4 2025.
SELLAS Life Sciences (SLS) Goodwill & Intangibles (2011 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has 16 years of Goodwill & Intangibles data on file, last reported at $1.9 million in Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $1.9 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (changed 0.0% YoY), and the FY2025 annual result was $1.9 million, up 0.74% from the prior year.
- Goodwill & Intangibles held at $1.9 million in Q1 2026 per SLS's latest filing, from $1.9 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $1.9 million in Q1 2022 and troughed at $1.9 million in Q4 2023.
- A 5-year average of $1.9 million and a median of $1.9 million in 2022 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles advanced 0.74% in 2022, then dropped 0.73% in 2023.
- A 5-year view of Goodwill & Intangibles shows it stood at $1.9 million in 2022, then declined by 0.73% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then advanced by 0.74% to $1.9 million in 2025, then changed by 0.0% to $1.9 million in 2026.
- Business Quant data shows SLS's Goodwill & Intangibles at $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.91 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 1.91 Mn |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.91 Mn |